Popular Trials
mRNA Vaccine
mRNA COVID-19 Vaccines Safety for Previous Vaccine Reactions
Recruiting4 awardsPhase 4
Ann Arbor, Michigan
This trial is being conducted to see if people who have had bad reactions to COVID-19 vaccines in the past can safely have another dose, or if people with a history of allergies can safely have the vaccine at all.
Virus Therapy
DAS181 for Respiratory Infections
Recruiting1 awardPhase 3
Duarte, California
This trial will enroll immunocompromised patients with Lower Tract parainfluenza infection to study the safety and efficacy of an investigational vaccine. A sub-study will also enroll patients with severe COVID-19.
Popular Filters
Trials for COVID-19 Patients
hIVIG for COVID-19
Recruiting1 awardPhase 3
Washington, District of Columbia
This trial is for people with recently diagnosed SARS-CoV-2 infection who do not require hospitalization. The goal is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo.
Virus Therapy
CoVLP for COVID-19
Recruiting0 awardsPhase 2 & 3
Birmingham, Alabama
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity and safety profile. The Phase 3 portion is an event-driven, randomized, observer blinded, placebo-controlled design that will evaluate the efficacy and safety of the CoVLP formulation compared to placebo. Subjects will be followed for safety and immunogenicity for a period of 12 months after the last vaccination.
Anti-metabolites
Decitabine for COVID-19
Recruiting0 awardsPhase 2
Baltimore, Maryland
This trial tests if the drug decitabine can safely and effectively treat severe lung issues in critically ill COVID-19 patients. Patients will receive either decitabine or standard care. The goal is to see if decitabine helps improve their condition by reducing lung damage.
Trials for PCS Patients
Procedure
BIO 300 Oral Suspension for Post-COVID Syndrome
Recruiting0 awardsPhase 2
Aurora, Colorado
This trial is testing whether BIO 300 Oral Suspension can improve lung function in patients who were hospitalized for severe COVID-19 and continue to experience post-acute respiratory complications. Patients will be randomly assigned to receive either BIO 300 or a placebo.
Neurostimulation
PENFS for Post-Concussion Syndrome
Recruiting0 awards
Orange, California
This trial tests a small device that sends electrical signals through tiny needles on the outer ear to help children with pain, post-concussion symptoms, and post-COVID-19 symptoms. The electrical signals aim to reduce pain and improve brain function by stimulating nerves in the ear. The use of electrical currents for the treatment of disease has been considered since antiquity but it has only been in recent years that suitable devices have been available to scientific investigators to provide stimulation currents for clinical use.
Mechanisms of Post COVID-19 Tachycardia Syndrome
Recruiting1 award2 criteria
Nashville, Tennessee
This trial tests a device that sends mild electrical signals to the ear to help people with long-term symptoms after COVID-19. It focuses on those who have ongoing issues like a fast heartbeat and dizziness. The device aims to reduce inflammation and improve these symptoms by stimulating a nerve that helps control these functions.
Behavioural Intervention
Ibudilast + Pentoxifylline for Long COVID
Recruiting0 awardsPhase 2 & 3
Toronto, Ontario
This trial will test two treatments to find the best way to help people with long-term COVID-19 symptoms. It will adapt based on early results, stopping ineffective treatments and adding new ones as needed.
Behavioral Intervention
Clinician Training Program for Long COVID
Recruiting1 award4 criteria
East Orange, New Jersey
This trial tests if a training program can help VA clinicians provide better care to Veterans with Long-COVID, including by engaging in conversations that validate experience, create a shared understanding, and develop an action plan.
Phase 3 Trials
hIVIG for COVID-19
Recruiting1 awardPhase 3
Washington, District of Columbia
This trial is for people with recently diagnosed SARS-CoV-2 infection who do not require hospitalization. The goal is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo.
Virus Therapy
CoVLP for COVID-19
Recruiting0 awardsPhase 2 & 3
Birmingham, Alabama
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity and safety profile. The Phase 3 portion is an event-driven, randomized, observer blinded, placebo-controlled design that will evaluate the efficacy and safety of the CoVLP formulation compared to placebo. Subjects will be followed for safety and immunogenicity for a period of 12 months after the last vaccination.
Trials With No Placebo
Behavioral Intervention
Communication Campaign for COVID-19 Vaccine Uptake
Recruiting1 award
Syracuse, New York
This trial will study if using information from wastewater surveillance of COVID-19 can help increase COVID-19 vaccine uptake in New York counties. The study will compare vaccination rates in counties that receive communication campaigns based
Behavioral Intervention
Stepped Alcohol Intervention for Alcohol-related Liver Disease
Recruiting1 award4 criteria
San Francisco, California
This trial is testing a new way to help people with chronic liver disease who have unhealthy alcohol use. The new treatment includes 3 sessions of motivational interviewing, and referral to addiction medicine if necessary. The trial will measure how well the new treatment works at 6 and 12 months.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.